Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.

Chandler MR, Keene KS, Tuomela JM, Forero-Torres A, Desmond R, Vuopala KS, Harris KW, Merner ND, Selander KS.

PLoS One. 2017 Sep 8;12(9):e0183832. doi: 10.1371/journal.pone.0183832. eCollection 2017.

2.

Bisphenol A Does Not Mimic Estrogen in the Promotion of the In Vitro Response of Murine Dendritic Cells to Toll-Like Receptor Ligands.

Chakhtoura M, Sriram U, Heayn M, Wonsidler J, Doyle C, Dinnall JA, Gallucci S, Roberts RA.

Mediators Inflamm. 2017;2017:2034348. doi: 10.1155/2017/2034348. Epub 2017 Jul 25.

3.

Extraordinarily potent proinflammatory properties of lactoferrin-containing immunocomplexes against human monocytes and macrophages.

Hu L, Hu X, Long K, Gao C, Dong HL, Zhong Q, Gao XM, Gong FY.

Sci Rep. 2017 Jun 26;7(1):4230. doi: 10.1038/s41598-017-04275-7.

4.

The many ways tissue phagocytes respond to dying cells.

Blander JM.

Immunol Rev. 2017 May;277(1):158-173. doi: 10.1111/imr.12537. Review.

PMID:
28462530
5.

Synthetic nanovaccines for immunotherapy.

Luo M, Samandi LZ, Wang Z, Chen ZJ, Gao J.

J Control Release. 2017 Oct 10;263:200-210. doi: 10.1016/j.jconrel.2017.03.033. Epub 2017 Mar 21.

PMID:
28336379
6.

The protective effect of the anti-Toll-like receptor 9 antibody against acute cytokine storm caused by immunostimulatory DNA.

Murakami Y, Fukui R, Motoi Y, Shibata T, Saitoh SI, Sato R, Miyake K.

Sci Rep. 2017 Mar 7;7:44042. doi: 10.1038/srep44042.

7.

Scavenging nucleic acid debris to combat autoimmunity and infectious disease.

Holl EK, Shumansky KL, Borst LB, Burnette AD, Sample CJ, Ramsburg EA, Sullenger BA.

Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9728-33. doi: 10.1073/pnas.1607011113. Epub 2016 Aug 15. Erratum in: Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6545.

8.

Methane limit LPS-induced NF-κB/MAPKs signal in macrophages and suppress immune response in mice by enhancing PI3K/AKT/GSK-3β-mediated IL-10 expression.

Zhang X, Li N, Shao H, Meng Y, Wang L, Wu Q, Yao Y, Li J, Bian J, Zhang Y, Deng X.

Sci Rep. 2016 Jul 11;6:29359. doi: 10.1038/srep29359.

9.

Siglec-H protects from virus-triggered severe systemic autoimmunity.

Schmitt H, Sell S, Koch J, Seefried M, Sonnewald S, Daniel C, Winkler TH, Nitschke L.

J Exp Med. 2016 Jul 25;213(8):1627-44. doi: 10.1084/jem.20160189. Epub 2016 Jul 4.

10.

BANK1 Regulates IgG Production in a Lupus Model by Controlling TLR7-Dependent STAT1 Activation.

Wu YY, Kumar R, Iida R, Bagavant H, Alarcón-Riquelme ME.

PLoS One. 2016 May 26;11(5):e0156302. doi: 10.1371/journal.pone.0156302. eCollection 2016.

11.

Regulatory Role of IL-1R8 in Immunity and Disease.

Molgora M, Barajon I, Mantovani A, Garlanda C.

Front Immunol. 2016 Apr 20;7:149. doi: 10.3389/fimmu.2016.00149. eCollection 2016. Review.

12.

Tissue-specific mRNA expression profiles of porcine Toll-like receptors at different ages in germ-free and conventional pigs.

Shao L, Fischer DD, Kandasamy S, Saif LJ, Vlasova AN.

Vet Immunol Immunopathol. 2016 Mar;171:7-16. doi: 10.1016/j.vetimm.2016.01.008. Epub 2016 Feb 1.

13.

Beyond antigens and adjuvants: formulating future vaccines.

Moyer TJ, Zmolek AC, Irvine DJ.

J Clin Invest. 2016 Mar 1;126(3):799-808. doi: 10.1172/JCI81083. Epub 2016 Mar 1. Review.

14.

Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.

Hamerman JA, Pottle J, Ni M, He Y, Zhang ZY, Buckner JH.

Immunol Rev. 2016 Jan;269(1):212-27. doi: 10.1111/imr.12381. Review.

15.

Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model.

Duffau P, Menn-Josephy H, Cuda CM, Dominguez S, Aprahamian TR, Watkins AA, Yasuda K, Monach P, Lafyatis R, Rice LM, Kenneth Haines G 3rd, Gravallese EM, Baum R, Richez C, Perlman H, Bonegio RG, Rifkin IR.

Arthritis Rheumatol. 2015 Dec;67(12):3146-57. doi: 10.1002/art.39321.

16.

Local Joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis.

Sohn DH, Rhodes C, Onuma K, Zhao X, Sharpe O, Gazitt T, Shiao R, Fert-Bober J, Cheng D, Lahey LJ, Wong HH, Van Eyk J, Robinson WH, Sokolove J.

Arthritis Rheumatol. 2015 Nov;67(11):2877-87. doi: 10.1002/art.39283.

17.

Tumor infiltrating CD8+ T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma.

Mella M, Kauppila JH, Karihtala P, Lehenkari P, Jukkola-Vuorinen A, Soini Y, Auvinen P, Vaarala MH, Ronkainen H, Kauppila S, Haapasaari KM, Vuopala KS, Selander KS.

Oncoimmunology. 2015 May 22;4(6):e1002726. eCollection 2015 Jun.

18.

TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.

Mongini PK, Gupta R, Boyle E, Nieto J, Lee H, Stein J, Bandovic J, Stankovic T, Barrientos J, Kolitz JE, Allen SL, Rai K, Chu CC, Chiorazzi N.

J Immunol. 2015 Aug 1;195(3):901-23. doi: 10.4049/jimmunol.1403189. Epub 2015 Jul 1.

19.

Innate immune activation by tissue injury and cell death in the setting of hematopoietic stem cell transplantation.

Brennan TV, Rendell VR, Yang Y.

Front Immunol. 2015 Mar 16;6:101. doi: 10.3389/fimmu.2015.00101. eCollection 2015. Review.

20.

CpGB DNA activates dermal macrophages and specifically recruits inflammatory monocytes into the skin.

Mathes AL, Rice L, Affandi AJ, DiMarzio M, Rifkin IR, Stifano G, Christmann RB, Lafyatis R.

Exp Dermatol. 2015 Feb;24(2):133-9. doi: 10.1111/exd.12603. Epub 2015 Jan 12.

Supplemental Content

Support Center